Fig. 4

The association between predicted model and other GVHD endpoint in total population. A The 100-day cumulative incidence of grade II to IV aGVHD in the low- and high-risk groups; B The rate of grade II to IV aGVHD of each organ in the low- and high-risk groups; C The 100-day cumulative incidence of grade I–IV aGVHD in the low- and high-risk groups; D The rate of grade I to IV aGVHD of each organ in the low- and high-risk groups